Strides Pharma Science consolidated net profit rises 77.07% in the December 2024 quarter
Sales rise 14.71% to Rs 1153.67 crore
Net profit of Strides Pharma Science rose 77.07% to Rs 87.95 crore in the quarter ended December 2024 as against Rs 49.67 crore during the previous quarter ended December 2023. Sales rose 14.71% to Rs 1153.67 crore in the quarter ended December 2024 as against Rs 1005.77 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var.Sales1153.671005.77 15 OPM %18.2312.87 -PBDT164.7068.49 140 PBT116.2819.04 511 NP87.9549.67 77Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Jan 30 2025 | 2:39 PM IST